{"lastClose": 6.289999961853027, "len": 1063, "date": "2022-12-30", "alpha_1": -0.03202052596258498, "beta_1": 1.6305993300492885, "drawup_1": 1.5486725887776869, "natr_1": 14.72839482715961, "sup_1": -0.04027553152181708, "res_1": 0.8701642912494089, "bullPattern_1": ["HAMMER"], "bearPattern_1": [], "rsi_1": 30.099227355462858, "adx_1": 53.42995828504278, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.7699317991168833, "stratHoldAlpha_1": 250.48613111821447, "stratHoldDrawdown_1": -0.6157005594807052, "alpha_3mo": -0.8983211605382813, "beta_3mo": 1.3770736339059875, "drawup_3mo": 0.22945207492744557, "natr_3mo": 14.72839482715961, "sup_3mo": -0.1542130799541448, "res_3mo": 0.30524643687411335, "bullPattern_3mo": ["CLOSINGMARUBOZU", "LONGLINE"], "bearPattern_3mo": [], "rsi_3mo": 17.58530190296803, "adx_3mo": 74.68024444099842, "drawdown_3mo": -0.49414940961034204, "stratHoldSharpe_3mo": -3.322764187145955, "stratHoldAlpha_3mo": 249.103640646642, "stratHoldDrawdown_3mo": -0.44533573050130937, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 907081869, "Name": "Allogene Therapeutics Inc.", "IPO Year": 2018.0, "Country": "United States", "alpha%_1": 0.6627024337824026, "beta%_1": 0.8945825083383299, "drawup%_1": 0.9996518131970296, "natr%_1": 0.9999693635492651, "drawdown%_1": 0.09559501830413303, "stratHoldSharpe%_1": 0.24459055902231736, "stratHoldAlpha%_1": 0.09222162354290298, "stratHoldDrawdown%_1": 0.09376378041543137, "alpha%_3mo": 0.07628531776774773, "beta%_3mo": 0.7899526044766905, "drawup%_3mo": 0.4370427715408126, "natr%_3mo": 0.9999616724090049, "drawdown%_3mo": 0.0010512373409350935, "stratHoldSharpe%_3mo": 0.008566652834881217, "stratHoldAlpha%_3mo": 9.662543147890406e-05, "stratHoldDrawdown%_3mo": 0.0011441838499699425}